Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway

Histology and Histopathology

Volumn 25, Issue 4, 2010, Pages 485-493

  Nam, C ^a   Doi, K ^a   Nakayama, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Cell cycle checkpoint; DNA damage; Etoposide; Neural progenitors

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; BROXURIDINE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; ETOPOSIDE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIVISION; DNA DAMAGE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL STEM CELL; FETUS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PREGNANCY; TELENCEPHALON;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BROMODEOXYURIDINE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; DNA DAMAGE; DNA-BINDING PROTEINS; ETOPOSIDE; FEMALE; FETAL STEM CELLS; FETUS; G2 PHASE; MATERNAL EXPOSURE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; NEURONS; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; TELENCEPHALON; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 77950190270     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bartek J., Lukas C. and Lukas J. (2004). Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 20045, 792-804.
2. Charrier-Savournin F.B., Chateau M.T., Gire V., Sedivy J., Piette J. and Dulic V. (2004). p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol. Biol. Cell. 15, 3965-3976.
3. Chen A.Y. and Liu L.F. (1994). DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34, 191-218.
4. Coverley D., Laman H. and Laskey R.A. (2002). Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat. Cell Biol. 4, 523-528.
5. Ding H., Duan W., Zhu W.G., Ju R., Srinivasan K., Otterson G.A. and Villalona-Calero M.A. (2003). p21 respense to DNA damage induced by genistein and etoposide in human lung cancer cells. Biochem. Biophys. Res. Commun. 305, 950-956.
6. DiTullio R.A., Mochan T.A., Venere M., Bartkova J., Sehested M., Bartek J. and Halazonetis T.D. (2002). 53BP1 functions in an ATMdependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4, 998-1002.
7. Downs J.A., Lowndes N.F. and Jackson S.P. (2000). A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408, 1001-1004.
8. D'Sa-Eipper C., Leonard J.R., Putcha G., Zheng T.S., Flavell R.A., Rakic P., Kuida K. and Roth K.A. (2001). DNA damage-induced neural precursor cell apoptosis requires p53 and caspase 9 but neither Bax nor caspase 3. Development 128, 137-146.
9. Fujita S. (2003) The discovery of the matrix cell, the identification of the multipotent neural stem cell and the development of the central nervous system. Cell Struct. Funct. 28, 205-228.
10. Gantchev T.G. and Hunting D.J. (1997). Enhancement of etoposide (VP-16) cytotoxicity by enzymatic and photodynamically induced oxidative stress. Anticancer Drugs 8, 164-173.
11. Ha L., Ceryak S. and Patierno S.R. (2003). Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278, 17885-17894.
12. Hande K.R. (1998). Etoposide: four decades of development of topoisomerase inhibitor. Eur. J. Cancer 34, 1514-1521.
13. Katayama K., Ueno M., Yamauchi H., Nagata T., Nakayama H. and Doi K. (2005) Ethylnitrosourea induces neural progenitor cell apoptosis after S-phase accumulation in a p53-dependent manner. Neurobiol. Dis. 18, 218-225.
14. Ko L.J. and Prives C. (1996) p53: puzzle and paradigm, Genes Dev. 10, 1054-1072.
15. Levine A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
16. Mailand N., Syljuasen R.G. and Lukas J. (2001). The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-8 47.
17. Nam C., Woo G.H., Uetsuka K., Nakayama H. and Doi K. (2006a). Histopathological changes in the brain of mouse fetuses by etoposide- administration. Histol. Histopathol. 21, 257-263.
18. Nam C., Yamauchi H., Nakayama H. and Doi K. (2006b). Etoposide induces apoptosis and cell cycle arrest of neuroepithelial cells in a p53-related manner. Neurotoxicol. Teratol. 28, 664-672.
19. Qian X., Shen Q., Goderie S.K., He W., Capela A., Davis A.A. and Temple S. (2000). Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron 28, 69-80.
20. Resnitzky D., Hengst L. and Reed S.I. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol. Cell. Biol. 15, 4347-4352.
21. Rivera A., Mavila A., Bayless K.J., Davis G.E. and Maxwell S.A. (2006). Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cell. Mol. Life Sci. 63, 1425-1439.
22. Robinson M.J. and Oscheroff N. (1991). Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II. Biochemistry 30, 1807-1813.
23. Samuel T., Weber H.O. and Funk J.O. (2002) Linking DNA damage to cell cycle checkpoints. Cell cycle 1, 162-168.
24. Sieber S.M., Whang-Peng J., Botkin C. and Knutsen T. (1978). Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colochicine, maytasine, VP-16-213 and VM-216) in mice. Teratology 18, 31-48.
25. Smits V.A., Klompmaker R., Vallenius T., Rijksen G., Makela T.P. and Madema R.H. (2000). p21 inhibits Thr161 phosphoryltation of Cdcw to enforce the G2 DNA damage checkpoint. J. Biol. Chem. 275, 30638-30648.
26. Stewart Z.A. and Pietenpol J.A. (2001) p53 signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243-263.
27. Taylor A.M. (1998). What has the cloning of the ATM gene told us about ataxia telangiectasia. Int. J. Radiat. Biol. 73, 365-371.
28. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y. and Aizawa S. (1993). Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8, 3313-3322.
29. Ueno M., Katayama K., Yamauchi H, Nakayama H. and Doi K. (2006). Cell cycle and cell death regulation of neural progenitor cells in the 5-azacytidine (5AzC)-treated developing fetal brain. Exp. Neurol. 198, 154-166.
30. Yoshikawa K. (2000). Cell cycle regulators in neural stem cells and postmitotic neurons. Neurosci. Res. 37, 1-14.